Adiponectin in eutrophic and obese children as a biomarker to predict metabolic syndrome and each of its components

BMC Public Health

Miguel Cruz¹  Jesús Peralta-Romero¹  Rebeca García-Macedo¹  Samuel Flores-Huerta²  Miguel Klünder-Klünder² 

[1] Medical Research Unit in Biochemistry, UMAE Bernardo Sepúlveda, Centro Médico Nacional Siglo XXI, IMSS, Mexico City, Mexico;Community Health Research Department, Hospital Infantil de México Federico Gómez, Ministry of Health (SSA), Mexico City, Mexico

关键词: Biomarker;    Metabolic syndrome;    Insulin resistance;    Child;    Adiponectin;    Obesity;   

Others  :  1162591
DOI  :  10.1186/1471-2458-13-88

 received in 2012-01-12, accepted in 2013-01-22,  发布年份 2013

【 摘 要 】

Background

Obesity is associated with the rise of noncommunicable diseases worldwide. The pathophysiology behind this disease involves the increase of adipose tissue, being inversely related to adiponectin, but directly related to insulin resistance and metabolic syndrome (MetS). Therefore, this study aimed to determine the relationship between adiponectin levels with each component of MetS in eutrophic and obese Mexican children.

Methods

A cross sectional study was conducted in 190 school-age children classified as obese and 196 classified as eutrophic. Adiponectin, glucose, insulin, high density lipoprotein cholesterol (HDL-C) and triglycerides were determined from a fasting blood sample. Height, weight, waist circumference, systolic and diastolic blood pressures (BP) were measured; MetS was evaluated with the IDF definition. The study groups were divided according to tertiles of adiponectin, using the higher concentration as a reference. Linear regression analysis was used to assess the association between adiponectin and components of the MetS. Finally, stepwise forward multiple logistic regression analysis controlling for age, gender, basal HOMA-IR values and BMI was performed to determine the odds ratio of developing MetS according to adiponectin tertiles.

Results

Anthropometric and metabolic measurements were statistically different between eutrophic and obese children with and without MetS (P <0.001). The prevalence of MetS in obese populations was 13%. Adiponectin concentrations were 15.5 ± 6.1, 12.0 ± 4.8, 12.4 ± 4.9 and 9.4 ± 2.8 μg/mL for eutrophic and obese subjects, obese without MetS, and obese with MetS, respectively (P <0.001). Obese children with low values of adiponectin exhibited a higher frequency of MetS components: abdominal obesity, 49%; high systolic BP, 3%; high diastolic BP, 2%; impaired fasting glucose, 17%; hypertriglyceridemia, 31%; and low HDL-C values, 42%. Adjusted odds ratio of presenting MetS according to adiponectin categories was 10.9 (95% CI 2.05; 48.16) when the first tertile was compared with the third.

Conclusion

In this sample of eutrophic and obese Mexican children we found that adiponectin concentrations and MetS components have an inversely proportional relationship, which supports the idea that this hormone could be a biomarker for identifying individuals with risk of developing MetS.

【 授权许可】

   
2013 Klünder-Klünder et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Bonvecchio A, Safdie M, Monterrubio EA, Gust T, Villalpando S, Rivera JA: Overweight and obesity trends in Mexican children 2 to 18 years of age from 1988 to 2006. Salud Pub Mex 2009, 51(Suppl 4):S586-S594.
• [2]Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, Villalpando-Hernández S, Hernández-Avila M, Sepúlveda-Amor J: Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2006.
• [3]Cruz M, Torres M, Aguilar-Herrera B, Pérez-Johnston R, Guzmán-Juárez N, Aranda M, Kumate J: Type 2 diabetes mellitus in children: An increasing health problem in Mexico. J Pediatr Endocrinol Metab 2004, 17(2):183-190.
• [4]Flores-Huerta S, Klünder-Klünder M, Reyes-de-la-Cruz L, Santos JI: Increase in body mass index and waist circumference is associated with high blood pressure in children and adolescents in Mexico City. Arch Med Res 2009, 40(3):208-215.
• [5]Borch-Johnsen K, Wareham N: The rise and fall of the metabolic syndrome. Diabetologia 2010, 53(4):597-599.
• [6]Simmons R, Alberti K, Gale E, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, et al.: The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010, 53(4):600-605.
• [7]Valle M, Martos R, Gascón F, Cañete R, Zafra MA, Morales R: Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes & Metabolism 2005, 31(1):55-62.
• [8]Körner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W: New predictors of the metabolic syndrome in children: Role of adipocytokines. Pediatr Res 2007, 61:640-645.
• [9]Cambuli VM, Musiu MC, Incani M, Paderi M, Serpe R, Marras V, Cossu E, Cavallo MG, Mariotti S, Loche S, et al.: Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J Clin Endocrinol Metab 2008, 93(8):3051-3057.
• [10]Kopp HP, Krzyzanowska K, Mohlig M, Spranger J, Pfeiffer AFH, Schernthaner G: Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes 2005, 29(7):766-771.
• [11]Martos-Moreno GA, Barrios V, Martinez G, Hawkins F, Argente J: Effect of weight loss on high-molecular weight adiponectin in obese children. Obesity 2010, 18(12):2288-2294.
• [12]Reinehr T, Roth C, Menke T, Andler W: Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004, 89(8):3790-3794.
• [13]Gilardini L, McTernan PG, Girola A, da Silva NF, Alberti L, Kumar S, Invitti C: Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis 2006, 189(2):401-407.
• [14]Shaibi GQ, Cruz ML, Weigensberg MJ, Toledo-Corral CM, Lane CJ, Kelly LA, Davis JN, Koebnick C, Ventura EE, Roberts CK, et al.: Adiponectin independently predicts metabolic syndrome in overweight Latino youth. J Clin Endocrinol Metab 2007, 92(5):1809-1813.
• [15]Shargorodsky M, Boaz M, Goldberg Y, Matas Z, Gavish D, Fux A, Wolfson N: Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis? Int J Obes 2009, 33(5):553-558.
• [16]Cizmecioglu FM, Etiler N, Ergen A, Gormus U, Keser A, Hekim N, Hamzaoglu O, Hatun S: Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence. Exp Clin Endocrinol Diabetes 2009, 117(EFirst):622-627.
• [17]Snehalatha C, Yamuna A, Ramachandran A: Plasma adiponectin does not correlate with insulin resistance and cardiometabolic variables in nondiabetic Asian Indian teenagers. Diabetes Care 2008, 31(12):2374-2379.
• [18]World Health Organization, Expert Committee: Physical status: The use and interpretation of anthropometry. In WHO technical report series 854. Geneva: Report of a WHO Expert Committee; 1995.
• [19]Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL: CDC growth charts for the United States: Methods and development. National Center for Health Statistics: Vital Health Stat 2000, 11(246):2002.
• [20]National high blood pressure education program working group on high blood pressure in children and adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(Suppl 2):555-576.
• [21]García-Cuartero B, García-Lacalle C, Jiménez-Lobo C, González-Vergaz A, Calvo-Rey C, Alcázar-Villar MJ, Díaz-Martínez E: Índice HOMA y QUICKI, insulina y péptido C en niños sanos. Puntos de corte de riesgo cardiovascular. An Pediatr (Barc) 2007, 66(5):481-490.
• [22]Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S: The metabolic syndrome in children and adolescents. Lancet 2007, 369(9579):2059-2061.
• [23]Fernández JR, Redden DT, Pietrobelli A, Allison DL: Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004, 145(4):439-444.
• [24]Klünder-Klünder M, Flores-Huerta S: Waist circumference values according to height percentiles: A proposal to evaluate abdominal obesity in Mexican children and adolescents between 6 and 16 years of age. Arch Med Res 2011, 42(6):515-522.
• [25]Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME: Earlier onset of puberty in girls: Relation to increased body mass index and race. Pediatrics 2001, 108(2):347-353.
• [26]Choi KM, Yannakoulia M, Park MS, Cho GJ, Kim JH, Lee SH, Hwang TG, Yang SJ, Kim TN, Yoo HJ, et al.: Serum adipocyte fatty acid-binding protein, retinol-binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: a 3-y prospective cohort study. Am J Clin Nutr 2011, 93(1):19-26.
• [27]Papoutsakis C, Yannakoulia M, Ntalla I, Dedoussis GV: Metabolic syndrome in a Mediterranean pediatric cohort: prevalence using International Diabetes Federation-derived criteria and associations with adiponectin and leptin. Metabolism: clinical and experimental 2012, 61(2):140-145.
• [28]Calcaterra V, Amici MD, Klersy C, Torre C, Brizzi V, Scaglia F, Albanesi M, Albertini R, Allais B, Larizza D: Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. ACTA BIOMED 2009, 80:117-123.
• [29]Suárez-Ortegón MF, Ramírez-Vélez R, Mosquera M, Méndez F, Aguilar-de Plata C: Prevalence of metabolic syndrome in urban Colombian adolescents aged 10–16 years using three different pediatric definitions. J Trop Pediatr 2012.
• [30]Chen F, Wang Y, Shan X, Cheng H, Hou D, Zhao X, Wang T, Zhao D, Mi J: Association between childhood obesity and metabolic syndrome: Evidence from a large sample of Chinese children and adolescents. PLoS ONE 2012, 7(10):e47380.
• [31]de Armas MG G, Monereo-Megías S, Merino-Viveros M, Iglesias-Bolaños P, Vega-Piñero B: Prevalencia de síndrome metabólico en una población de niños y adolescentes con obesidad. Endocrinol Nutr 2012, 59(3):155-159.
• [32]Juárez-López C, Klünder-Klünder M, Medina-Bravo P, Madrigal-Azcárate A, Mass-Díaz E, Flores-Huerta S: Insulin resistance and its association with the components of metabolic syndrome among obese children and adolescents. BMC Public Health 2010, 10(1):318. BioMed Central Full Text
• [33]Hindle A, Edwards C, McCaffrey T, Fu S, Brody F: Reactivation of adiponectin expression in obese patients after bariatric surgery. Surgical Endoscopy 2010, 24(6):1367-1373.
• [34]Cruz M, García-Macedo R, García-Valerio Y, Gutiérrez M, Medina-Navarro R, Durán G, Wacher N, Kumate J: Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care 2004, 27:1451-1453.
• [35]Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. Diabetes Care 2003, 26(7):2015-2020.
• [36]Cook JR, Semple RK: Hypoadiponectinemia–Cause or Consequence of Human "Insulin Resistance"? J Clin Endocrinol Metab 2010, 95(4):1544-1554.
• [37]Medina-Bravo P, Meza-Santibáñez R, Rosas-Fernández P, Galván-Duarte R, Saucedo-García R, Velázquez-López L, Torres-Tamayo M: Decrease in serum adiponectin levels associated with visceral fat accumulation independent of pubertal stage in children and adolescents. Arch Med Res 2011, 42(2):115-121.
• [38]Rasmussen-Torvik LJ, Pankow JS, Jacobs DR Jr, Steinberger J, Moran AM, Sinaiko AR: Influence of waist on adiponectin and insulin sensitivity in adolescence. Obesity 2009, 17(1):156-161.